Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297535914> ?p ?o ?g. }
- W4297535914 endingPage "106168" @default.
- W4297535914 startingPage "106168" @default.
- W4297535914 abstract "Alzheimer's disease (AD) is characterized by progressive cognitive impairment and mental behavior. The combination inhibition of two essential AD targets, acetylcholinesterase (AChE) and glycogen synthase kinase-3β (GSK-3β), might be a breakthrough in the discovery of therapeutic success. Herein, 17 β-carboline-1,2,3-triazole hybrids were designed, synthesized, and evaluated for their AChE and GSK-3β inhibitory potential. The results indicated that compound 21 has the most potent inhibition against eeAChE (IC50 = 0.20 ± 0.02 μM), hAChE (IC50 = 0.34 ± 0.01 μM) and GSK-3β (IC50 = 1.14 ± 0.05 μM) among these compounds. In addition, it inhibited hAChE in a mixed type manner and could occupy the binding pocket forming diverse interactions with the target of AChE and GSK-3β. Moreover, compound 21 showed low cytotoxicity against SH-SY5Y and HepG2 cell lines and good BBB permeability. Compound 21 also attenuated the tau hyperphosphorylation in the Tau (P301L) 293T cell model. The ADME projection exhibited that compound 21 has acceptable physicochemical characteristics. This study provides new leads for the assessment of AChE and GSK-3β dual inhibition as a promising strategy for AD treatment." @default.
- W4297535914 created "2022-09-29" @default.
- W4297535914 creator A5010465278 @default.
- W4297535914 creator A5021234204 @default.
- W4297535914 creator A5021687717 @default.
- W4297535914 creator A5023971504 @default.
- W4297535914 creator A5024048661 @default.
- W4297535914 creator A5027622336 @default.
- W4297535914 creator A5044663247 @default.
- W4297535914 creator A5056670831 @default.
- W4297535914 creator A5060119298 @default.
- W4297535914 creator A5068377419 @default.
- W4297535914 creator A5080918455 @default.
- W4297535914 creator A5084124309 @default.
- W4297535914 creator A5086539791 @default.
- W4297535914 date "2022-12-01" @default.
- W4297535914 modified "2023-10-16" @default.
- W4297535914 title "Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment" @default.
- W4297535914 cites W1572154908 @default.
- W4297535914 cites W1785177004 @default.
- W4297535914 cites W1971048984 @default.
- W4297535914 cites W1973851363 @default.
- W4297535914 cites W1991248573 @default.
- W4297535914 cites W2010236131 @default.
- W4297535914 cites W2026976753 @default.
- W4297535914 cites W2066418831 @default.
- W4297535914 cites W2107330191 @default.
- W4297535914 cites W2110089433 @default.
- W4297535914 cites W2112006614 @default.
- W4297535914 cites W2226159598 @default.
- W4297535914 cites W2273574810 @default.
- W4297535914 cites W2345866556 @default.
- W4297535914 cites W2466814158 @default.
- W4297535914 cites W2555174045 @default.
- W4297535914 cites W2560644411 @default.
- W4297535914 cites W2737051217 @default.
- W4297535914 cites W2775908724 @default.
- W4297535914 cites W2786033877 @default.
- W4297535914 cites W2789073476 @default.
- W4297535914 cites W2801842911 @default.
- W4297535914 cites W2809744404 @default.
- W4297535914 cites W2886532357 @default.
- W4297535914 cites W2888942873 @default.
- W4297535914 cites W2914185978 @default.
- W4297535914 cites W2949864276 @default.
- W4297535914 cites W2963661494 @default.
- W4297535914 cites W2967034887 @default.
- W4297535914 cites W2969291614 @default.
- W4297535914 cites W2981133434 @default.
- W4297535914 cites W2994491348 @default.
- W4297535914 cites W3003712216 @default.
- W4297535914 cites W3017214563 @default.
- W4297535914 cites W3017332432 @default.
- W4297535914 cites W3080958518 @default.
- W4297535914 cites W3113106243 @default.
- W4297535914 cites W3123514797 @default.
- W4297535914 cites W3126662165 @default.
- W4297535914 cites W3137059897 @default.
- W4297535914 cites W3164767006 @default.
- W4297535914 cites W3167568341 @default.
- W4297535914 cites W4200251225 @default.
- W4297535914 cites W4200280695 @default.
- W4297535914 cites W4211008088 @default.
- W4297535914 cites W4293412628 @default.
- W4297535914 cites W604053351 @default.
- W4297535914 doi "https://doi.org/10.1016/j.bioorg.2022.106168" @default.
- W4297535914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36191431" @default.
- W4297535914 hasPublicationYear "2022" @default.
- W4297535914 type Work @default.
- W4297535914 citedByCount "4" @default.
- W4297535914 countsByYear W42975359142023 @default.
- W4297535914 crossrefType "journal-article" @default.
- W4297535914 hasAuthorship W4297535914A5010465278 @default.
- W4297535914 hasAuthorship W4297535914A5021234204 @default.
- W4297535914 hasAuthorship W4297535914A5021687717 @default.
- W4297535914 hasAuthorship W4297535914A5023971504 @default.
- W4297535914 hasAuthorship W4297535914A5024048661 @default.
- W4297535914 hasAuthorship W4297535914A5027622336 @default.
- W4297535914 hasAuthorship W4297535914A5044663247 @default.
- W4297535914 hasAuthorship W4297535914A5056670831 @default.
- W4297535914 hasAuthorship W4297535914A5060119298 @default.
- W4297535914 hasAuthorship W4297535914A5068377419 @default.
- W4297535914 hasAuthorship W4297535914A5080918455 @default.
- W4297535914 hasAuthorship W4297535914A5084124309 @default.
- W4297535914 hasAuthorship W4297535914A5086539791 @default.
- W4297535914 hasConcept C109316439 @default.
- W4297535914 hasConcept C181199279 @default.
- W4297535914 hasConcept C182996813 @default.
- W4297535914 hasConcept C184235292 @default.
- W4297535914 hasConcept C185592680 @default.
- W4297535914 hasConcept C192118531 @default.
- W4297535914 hasConcept C202751555 @default.
- W4297535914 hasConcept C2777752497 @default.
- W4297535914 hasConcept C2778816929 @default.
- W4297535914 hasConcept C2779059548 @default.
- W4297535914 hasConcept C55493867 @default.
- W4297535914 hasConcept C69366308 @default.
- W4297535914 hasConcept C86803240 @default.